Drugs / Povidone-iodide
last change Oct 2021 re-read 2 minutes ago

Povidone-iodide

Developed for
COVID-19

Trials 0

Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT04584684 Comparator Dec 2020 → Oct 2021 COVID-19 University of North Carolina, Chapel Hill Terminated No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Povidone-iodide ClinicalTrials.gov intervention name — accepted as the source's own label NCT04584684
Route Other “Subject participants will rinse mouth one time for 60 seconds with 10 mL .5% w/v povidone-iodide.” NCT04584684